Stem-cell therapy for Parkinson's shows 'strong promise' in relieving symptoms
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have announced progress on that front — they have developed a new therapy that uses stem cells to treat advanced Parkinson's.
In the phase 1 trial, the researchers used donated stem cells (taken from early-stage embryos) to create nerve cells (neurons) and transplanted them into the brains of 12 Parkinson's patients, according to a press release from MSK.
Once the cells are injected, they produce dopamine, a hormone in the brain that helps with movement and coordination.
(One of the hallmarks of Parkinson's is low levels of dopamine, which causes the typical symptoms of tremors, stiffness, balance issues and difficulty walking.)
After 18 months, the injected cells had "taken hold in the brain with no serious side effects," the researchers reported.
Based on the MDS-UPDRS — a ratings scale for symptoms developed by the International Parkinson and Movement Disorder Society — the participants experienced "noticeable improvements," especially the group that received a higher dose.
Patients in the high-dose group reported 2.7 hours of additional "on time" each day.
"Neurologists say things usually get a little bit worse every year with this disease, meaning the score goes up by a few points," study co-author Lorenz Studer, MD, director of MSK's Center for Stem Cell Biology, said in the press release.
"In our study, not only did the score not get worse, it dropped by more than 20 points in the high-dose group."
On average, patients in the high-dose group reported 2.7 hours of additional "on time" — indicating periods of normal functioning with minimal symptoms — "a result that could be quite meaningful for their everyday life," Studer noted.
Given the success of the phase 1 trial, the U.S. Food and Drug Administration (FDA) has granted approval for the researchers to go straight to a phase 3 clinical trial in a much larger patient group — around 100 people — which will take place in the first half of 2025.
The findings were published in the journal Nature.
"The study showed that developing specific nerve cells from human embryonic stem cells in the lab, then injecting them in the brain of people with Parkinson's disease, is safe and holds significant promise as a possible future treatment," lead study author Viviane Tabar, MD, chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York City, told Fox News Digital.
"The findings were rewarding, as this work is more than a dozen years in the making."
Dr. Mary Ann Picone, medical director of the MS Center at Holy Name Medical Center in Teaneck, New Jersey, said that cells for the treatment of Parkinson's disease could offer potential for not only slowing disability, but also stopping progression and bringing about improvement in motor function.
"Although there is risk involved in the immune suppression necessary before the stem cell implantation and the procedure itself, it would be a major step forward in replacing the dopaminergic neurons lost in the disease," Picone, who was not involved in the study, told Fox News Digital.
Levodopa, currently the first-line treatment for Parkinson's, is limited in that patients need greater dosage amounts as time goes on, according to Picone — "and regulating off and on periods of either stiffness or dyskinesias (uncontrolled muscle movements) becomes more difficult."
Dr. Ann Murray, director of movement disorders at WVU Rockefeller Neuroscience Institute in West Virginia, referred to the study as "unbelievably exciting" for Parkinson's patients.
"Although the goal of this particular research project was to ensure safety, getting that significant clinical improvement in the UPDRS is absolutely groundbreaking," Murray told Fox News Digital. (She also was not involved in the study.)
"This is just the first step in getting this type of therapy approved for patients suffering from Parkinson's disease, but this is an amazing first step for the potential benefits of stem cell brain therapy."
There were some limitations associated with the study, Tabar noted.
"This is a small study designed to show safety — it is critical to conduct a larger, well-controlled study to prove that the treatment indeed works, otherwise referred to as a Phase 3 'efficacy' study," she said.
"This is an amazing first step for the potential benefits of stem cell brain therapy."
These early findings, however, are "suggestive of a strong promise."
"I think we can finally say that stem cells, when derived and differentiated properly, hold great promise to repair the brain in Parkinson's and potentially in other conditions someday," Tabar said.
The cell therapy was developed at MSK and was licensed to BlueRock Therapeutics in Massachusetts, which funded the study.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
9 hours ago
- Fox News
Hidden sleep danger could increase risk of 172 diseases, major study reveals
Experts agree that seven to nine hours of sleep is ideal for most adults — but when it comes to your health, the total number of hours might not be the most important factor. In a major new study led by teams from Peking University and Army Medical University, sleep irregularity has been linked to an increased risk of 172 different diseases. The researchers analyzed nearly seven years of UK Biobank sleep data from 88,461 adults averaging 62 years of age, focusing on multiple traits that included nocturnal sleep duration, sleep onset timing, sleep rhythm and sleep fragmentation, according to a press release. They then compared that data to disease outcomes from the National Health Service, the Cancer Registry and the National Death Index. They found that for 92 diseases — Parkinson's disease and acute kidney failure — 20% of the risk was tied to poor sleep behavior. Forty-two diseases were linked to at least double the risk. Those included age-related frailty, gangrene, and fibrosis and cirrhosis of the liver. Poor sleep traits were linked to 1.5 times the risk of 122 diseases, including type 2 diabetes mellitus, respiratory failure, certain bone fractures and urinary incontinence. Inflammatory pathways were identified as one possible link between irregular sleep and disease. "Some common diseases showed considerable attributable risk, such as Parkinson's disease, pulmonary heart disease, type 2 diabetes mellitus, obesity, thyrotoxicosis (hyperthyroidism) and urinary incontinence," the researchers wrote. The results were published in the journal Health Data Science. "Our findings underscore the overlooked importance of sleep regularity," said Prof. Shengfeng Wang, senior author of the study, in the release. "It's time we broaden our definition of good sleep beyond just duration." "It's time we broaden our definition of good sleep beyond just duration." Ashley Curtis, PhD, assistant professor and director of the Cognition, Aging, Sleep, and Health (CASH) Lab in the College of Nursing at the University of South Florida, was not involved in the research but shared her reaction to the findings. "This study contributes to the growing evidence supporting the critical role sleep plays as a key modifiable risk factor across a range of medical disorders, particularly in mid- to late-life," she told Fox News Digital. "However, this study also emphasizes that how we measure sleep matters in terms of what conclusions we make regarding its impact on health across the lifespan." Curtis highlighted the difference between self-reported sleep patterns versus objective measurements captured by wearable devices. "Better understanding these patterns is important, because it can impact recommendations regarding what aspects of sleep we should be monitoring more closely in terms of assessing the risk of future declines in health," she said. "Additionally, these findings provide insight into the specific physiological sleep-related mechanisms that may be driving comorbid disease trajectories." The researchers noted several major limitations in this research. The most prevalent is that the study is not representative of the nationwide population, as the participants were mainly middle-aged or elderly and therefore more susceptible to certain diseases. The sleep data was also captured at only one single point in time. There is also a chance that external factors or "reverse causation bias" affected the results, they stated. Curtis echoed these limitations, noting that sleep was only measured across one seven-day time period and did not consider variability in sleep patterns over time. "Further, there was a lack of consideration of sleep disorders, such as insomnia or sleep apnea," she told Fox News Digital. "Given that both of these sleep disorders are highly prevalent in aging populations, there is a need for future studies that include a more comprehensive clinical assessment in order to fully elucidate the link between sleep disorder profiles and the risk of other medical comorbidities." For more Health articles, visit The research team plans to conduct future studies to confirm causality and to measure how sleep interventions may impact chronic disease outcomes. The study was supported by the National Key R&D Program of China, the National Natural Science Foundation of China and the Beijing Municipal Health Development Research Fund.
Yahoo
a day ago
- Yahoo
NYC Gunman Blamed This Rare Brain Disease For His Mental Illness
On Monday night, a gunman killed four people and himself in Manhattan in an attack that reportedly targeted the NFL's headquarters in the city. The gunman, Shane Tamura, left behind a note in which he said he'd been suffering from chronic traumatic encephalopathy, or CTE, as a result of playing football. He had asked for his brain to be studied as part of CTE research. The discourse about football's impact on the brain is not new to the NFL. Both players and their families have sued the league time and time again over the matter of brain damage and its effects on players' post-career lives. CTE is a 'progressive neurodegenerative disease,' explained Dr. Jeremy Tanner, an assistant professor of neurology at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio. Research shows that football players, along with other people who participate in high-contact sports and activities, are more likely to develop the disease. A study out of Boston University's CTE Center found 40% of athletes under 30 had developed early signs of the disease upon their death. Another study out of BU found that roughly 91% of studied NFL players had the disease when they died. Experts told HuffPost that CTE research is ongoing, but there are clear links between head injuries, behavioral changes and the disease itself. Here's what to know: What is CTE? Like other brain diseases, such as Alzheimer's disease or Parkinson's disease, CTE affects how we think, behave, move and 'really anything that the brain is responsible for,' said Dr. Daniel H. Daneshvar, the co-director of Mass General Brigham Sports Concussion Clinic. 'It occurs in patients that have sustained traumatic brain injury, so blows to the head that may or may not have resulted in concussions,' said Dr. Aaron S. Lord, the chief of neurology and program director for clinical research at NYU Langone Hospital–Brooklyn. The more head injuries that occur, the higher the risk of developing chronic traumatic encephalopathy, Lord added. The thought pattern used to be that concussions increased CTE risk, but this isn't the case, added Daneshvar. 'Concussions themselves aren't what drives CTE risk. It's a repeated traumatic brain injury to the tune of hundreds or thousands over the course of decades that... increases the risk of someone having CTE,' he said, adding that the number of traumatic brain injuries also affects the severity of the disease. Can someone be diagnosed with CTE? You can't walk into a doctor's office and get a diagnosis of CTE. Right now, it can only be diagnosed after death, during an autopsy, said Lord. That means that people who may or may not have CTE can still get a gun license, a fact that can get lost in the discourse on social media about Tamura carrying the weaponry he had. The New York Police Department reported he had a 'documented mental health history,' but it's unclear if this would restrict his gun access. People who play contact sports are at higher risk — but any activity that involves frequent head impact is a risk factor. Specifically, CTE has been identified in players who engage in contact sports such as football, rugby, hockey and rodeo, said Tanner, adding that it's also been seen in soccer players. 'And it seems... the more total years played, the higher the risk,' Tanner said. It often is developed over time, after someone stops playing the sport, or the head trauma ends, explained Tanner. Daneshvar added that 'we've also seen [it] in individuals who experience intimate partner violence, in individuals who serve in the military.' Again, Daneshvar notes, the more often the head injury happens, the higher the risk of CTE. 'Famously, in the literature, there was a circus clown who was repeatedly shot out of a cannon and who was found to have CTE,' he said. CTE can cause behavioral changes and memory problems. 'Chronic traumatic encephalopathy [is] typically associated with changes in cognition and in behavior,' said Tanner. 'In behavior, a common symptom is what's called neurobehavioral dysregulation. For some people, this can present as a shortened fuse or more or irritability or agitation,' Tanner said. For others, this can mean paranoia, aggression, impulse control issues and trouble regulating emotions, he added. Neurobehavioral dysregulation tends to be more common in 'those affected by the disease in younger stages,' Tanner noted. 'Additionally, chronic traumatic encephalopathy is associated with changes in memory and with executive function, particularly planning, organization, multitasking... managing information and integrating it.' 'And those symptoms seem to be more common in older adults with the disease,' he added. It's important to note that a lot of these symptoms can also be signs of other neurological disorders or mental health diseases, said Tanner. In the end, individuals with a CTE diagnosis had problems with thinking, memory and behavior, said Daneshvar. But, once again, these things can be related to a multitude of other issues. 'We can't say for sure what clinical signs someone presents with are related to CTE pathology versus something else because humans are complex. We have a lot of different reasons for the way we behave,' said Daneshvar. If you do notice mental health changes, memory issues or other neurological problems, Tanner advises people to see a specialist for an evaluation. 'It's often a neurologist or a psychiatrist or a sports medicine specialist who has expertise in evaluating those with repetitive head impacts in sports,' Tanner said. 'It can be hard to distinguish what's the primary cause, and so looking at the number of years of head impact exposure can be a clue that there could be an increased risk for CTE.' Seeking medical attention for any neurological changes is essential, whether you're dealing with CTE or not. 'I see individuals who have histories of repeated traumatic brain injuries and are experiencing problems now, and I can't say with certainty whose problems are related to CTE versus not... but what I can do, and what I do every day, is treat them, and our treatments for people's symptoms are successful,' said Daneshvar. While there is no cure for CTE, doctors can still help, Daneshvar noted. 'I think that's a really important message, too. I think people think that CTE is some incurable, immovable thing, right? And it is treatable.' CTE has been linked to violence in some cases, but not always. ″In some cases, [CTE] has been linked to violent and aggressive behaviors,' Tanner said. One of the most talked about cases of CTE is that of Aaron Hernandez, a deceased former football player who was convicted of murder. 'The short fuse, the impulse control. One way to think about it could be when you're playing sports, you can turn [your aggression] on and off. You lose that ability to control the 'on and off' switch you use to regulate your aggression when on the field and off the field,' Tanner explained. There are some things you can do to lower your risk of CTE. As mentioned above, people who take part in particular sports or activities, such as football and rugby, are at higher risk of CTE. But there are a few habits that can help protect your brain. Lord added that wearing a helmet — whether that's on a bike ride or while playing football — is also an important way to protect yourself. Tanner suggests that instead of playing tackle football, try playing flag or touch football. 'We have a lot more to learn about how to prevent this disease,' Tanner said. 'What I would suggest is trying to minimize, as much as [you're] able, head contact and head impacts.' 'For former football players and others, there's the new Diagnose CTE study that's really looking at trying to understand how we can identify these symptoms during life and better understand this disease,' Tanner said. The study is actively recruiting former football players to learn about the unknowns of the disease. If you or someone you know needs help, call or text 988 or chat for mental health support. Additionally, you can find local mental health and crisis resources at Outside of the U.S., please visit the International Association for Suicide Prevention. Related... NYC Gunman Reportedly Left Note Blaming Specific Factor For His Mental Illness Gunman Opens Fire In Manhattan Office Building, Killing 4
Yahoo
a day ago
- Yahoo
AI Can Diagnose You with This Progressive Illness — and It's 86% Accurate, Study Says
Researchers developed an AI-powered tool that prompts users to perform neurological tests in their own homesNEED TO KNOW A tool accessible via smart home devices can help diagnose people with Parkinson's disease. The AI-powered tool was developed as part of a study by scientists at University of Rochester. The tool prompts users to perform neurological tests in their own homes that involve speech, facial expression and finger movementsA tool accessible via smart home devices can help diagnose people with Parkinson's disease. The AI-powered tool, called PARK, was developed as part of a study by scientists at University of Rochester. According to the website, the tool prompts users to perform a variety of web-based neurological tests in their own homes that involve speech, facial expression and finger movements. The tasks are then analyzed to detect whether the user shows signs of Parkinson's disease. After the results are given, the tool provides personalized resources for treatment or care. Newsweek reports that the test asks users to recite two short sentences that use every letter of the alphabet at least once. Then, in mere seconds, the AI can analyze the recordings to look for patterns linked to the disease. The toll has an 86% accuracy rate, per Newsweek. PARK can be accessed by any major web browser, but the researchers also note that it can be a useful tool for smart home devices, such as Amazon Alexa or Google Assistant. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human-interest stories. "While we haven't established partnerships with these companies yet, our model is very lightweight and well-suited for such integration," computer scientist Tariq Adnan told Newsweek. "With appropriate privacy safeguards and user consent, it could operate passively or on-demand through such widely used home devices,' he added. 'Once integrated, [in theory] a user could say something like 'screen me for Parkinson's symptoms,' and the system would prompt a short sentence to be read aloud.' The tool was trained with data from over 1,300 participants in home care settings, clinical settings and at the InMotion Parkinson's disease care center in Ohio, according to Newsweek. Possible indicators for the disease include uttering sounds, pausing, breathing and adding "features of unintelligibility," according to computer science graduate student Abdelrahman Abdelkader. The researchers note that access to neurological care can be a barrier for people to receive clinical diagnoses, and believe the tool can be used to encourage people to seek medical evaluation if they suspect they have the disease. "We envision a gentle, user-centered experience. The tool would never deliver a diagnosis, rather would only flag whether a follow-up with a clinician might be worthwhile," Adnan said. Parkinson's disease is characterized by the loss of nerve cells in the brain, per Mayo Clinic. It is unknown what causes the disease, although genes and environmental factors may play a risk. The average onset of Parkinson's disease is around 70 years old. Symptoms of the disease include memory loss, trouble with language, feeling irritable, having trouble chewing and swallowing, and difficulty sleeping. Parkinson's Foundation states that about 1.1 million people in the United States have the disease. Read the original article on People
